drug
degarelix acetate
Marketedupdated 3mo agoby Ferring Pharmaceuticals Inc
Approvedcommunity read0 votes
indications
investigational
Prostate Cancer
all catalysts(0)
nothing on the calendar yet
Trials studying degarelix acetate
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 10, 2029
~2.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (18)
- Apr 27, 2032method-of-use (U-1895)US 10695398
- Apr 27, 2032method-of-use (U-1895)US 10695398
- Apr 27, 2032method-of-use (U-1978)US 11766468
- Apr 27, 2032method-of-use (U-1978)US 11766468
- Apr 27, 2032method-of-use (U-1978)US 11826397
- Apr 27, 2032method-of-use (U-1978)US 11826397
- Apr 27, 2032method-of-use (U-1895)US 9415085
- Apr 27, 2032method-of-use (U-1895)US 9415085
- Feb 20, 2029method-of-use (U-1978)US 125148982.5y
- Feb 20, 2029method-of-use (U-1978)US 125148982.5y
- Feb 20, 2029method-of-use (U-4417)US 125333872.5y
- Feb 20, 2029method-of-use (U-4417)US 125333872.5y
- Feb 10, 2029method-of-use (U-1978)US 107297392.5y
- Feb 10, 2029method-of-use (U-1978)US 107297392.5y
- Feb 10, 2029method-of-use (U-1978)US 109738702.5y
- Feb 10, 2029method-of-use (U-1978)US 109738702.5y
- Feb 10, 2029method-of-use (U-1978)US 95793592.5y
- Feb 10, 2029method-of-use (U-1978)US 95793592.5y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 34m ago
Found something off?
comments(0)
5-min edit window · permanent after that